Finance

Lists
FPH:NZE
Fisher & Paykel Healthcare Corporatn Ltd
NZ$47,70
+0,61%
(+0,29) 1D
9 Okt., 16:59:43 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for FPH...
Open
NZ$47,41
High
NZ$47,99
Low
NZ$47,00
Mkt. cap
28,06 mjd
Avg. vol.
511,43 k
Volume
351,13 k
Dividend
1,09%
Quarterly dividend
NZ$0,13
Ex-dividend date
22 Jun. 2026
P/E ratio
60,17
52-wk high
NZ$47,99
52-wk low
NZ$32,16
EPS
NZ$0,79
Shares outstanding
588,27 m
No. of employees
7 k
Open
NZ$47,41
High
NZ$47,99
Low
NZ$47,00
Mkt. cap
28,06 mjd
Avg. vol.
511,43 k
Volume
351,13 k
Dividend
1,09%
Quarterly dividend
NZ$0,13
Ex-dividend date
22 Jun. 2026
P/E ratio
60,17
52-wk high
NZ$47,99
52-wk low
NZ$32,16
EPS
NZ$0,79
Shares outstanding
588,27 m
No. of employees
7 k
News stories
From web sources and news partners
Profile
Fisher & Paykel Healthcare Corporation Limited is a manufacturer, designer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. Based in New Zealand, their products and systems are sold in around 120 countries worldwide. FPH is primarily an exporting company, with just 1 percent of revenue coming from New Zealand sales. Wikipedia
About Fisher & Paykel Healthcare Corporatn Ltd
CEOLewis G. Gradon
Employees7,4 k
Founded1934
HeadquartersAuckland, Auckland, Nieu-Seeland
SectorMedical device
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
544,25 m
544,25 m
609,95 m
609,95 m
Cost of goods sold
201,40 m
201,40 m
217,75 m
217,75 m
Cost of revenue
201,40 m
201,40 m
217,75 m
217,75 m
Research and development expenses
57,05 m
57,05 m
60,70 m
60,70 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142,75 m
142,75 m
156,35 m
156,35 m
Operating expense
199,80 m
199,80 m
217,05 m
217,05 m
Total operating expenses
401,20 m
401,20 m
434,80 m
434,80 m
Operating income
143,05 m
143,05 m
175,15 m
175,15 m
Other non operating income
-
-
-
-
EBT including unusual items
141,90 m
141,90 m
173,85 m
173,85 m
EBT excluding unusual items
141,90 m
141,90 m
173,85 m
173,85 m
Income tax expense
35,40 m
35,40 m
46,10 m
46,10 m
Effective tax rate
24,95%
24,95%
26,52%
26,52%
Other operating expenses
-
-
-
-
Net income
106,50 m
106,50 m
127,75 m
127,75 m
Net profit margin
19,57%
19,57%
20,94%
20,94%
Earnings per share
-
-
-
-
Interest and investment income
2,05 m
2,05 m
2,05 m
2,05 m
Interest expense
-2,75 m
-2,75 m
-2,40 m
-2,40 m
Net interest expenses
-700,00 k
-700,00 k
-350,00 k
-350,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
174,95 m
174,95 m
204,75 m
204,75 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme